Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Completed 2

Sponsor Class

NETWORK 2OTHER 1NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

Sarcoma 2

Conditions

Osteosarcoma 2Stomach Neoplasms 1Sarcoma 1Prostatic Neoplasms 1Lung Neoplasms 1Hepatoblastoma 1Fibrolamellar hepatocellular carcinoma 1Esophageal Neoplasms 1Childhood Acute Myeloid Leukemia/Other Myeloid Malignancies 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Medullary 1Carcinoma, Hepatocellular 1Adenocarcinoma Of Esophagus 1

Interventions

Ifosfamide 5Doxorubicin 4Specimen Handling 3Methotrexate 3Etoposide 3Cisplatin 3Sorafenib 2Granulocyte Colony-Stimulating Factor 2Filgrastim 2sodium thiosulfate 1sargramostim 1pepinemab 1peginterferon alfa-2b 1mifamurtide 1merphos 1lorukafusp alfa 1irinotecan sucrosofate 1imetelstat 1etoposide phosphate 1Zoledronic Acid 1X-Rays 1Thrombopoietin 1Thoracotomy 1Thoracostomy 1Thoracoscopy 1Surgical Procedures, Operative 1Reverse Transcriptase Polymerase Chain Reaction 1Restraint, Physical 1Razoxane 1Radiotherapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
NETWORK × Osteosarcoma × Sorafenib × Clear all
NCT01804374 2015-06-17

SERIO

Italian Sarcoma Group

Phase 2 Completed
38 enrolled
Sarcoma

Sarcoma, Osteosarcoma

NCT00889057 2013-03-28

Sorafenib in Relapsed High Grade Osteosarcoma

Italian Sarcoma Group

Phase 2 Completed
35 enrolled
Sarcoma

Osteosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡